THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 119 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,912,000 | +5.3% | 93,700 | -8.3% | 0.00% | 0.0% |
| Q4 2020 | $1,816,000 | +17.8% | 102,209 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $1,541,000 | -28.8% | 104,209 | +1.1% | 0.00% | -50.0% |
| Q2 2020 | $2,163,000 | -7.9% | 103,063 | +1.4% | 0.00% | -33.3% |
| Q1 2020 | $2,348,000 | -9.9% | 101,609 | +1.0% | 0.00% | +50.0% |
| Q4 2019 | $2,605,000 | +63.1% | 100,622 | +22.8% | 0.00% | 0.0% |
| Q3 2019 | $1,597,000 | +56.0% | 81,966 | +30.7% | 0.00% | +100.0% |
| Q2 2019 | $1,024,000 | -18.1% | 62,715 | +13.6% | 0.00% | -50.0% |
| Q1 2019 | $1,251,000 | -13.8% | 55,200 | -2.6% | 0.00% | 0.0% |
| Q4 2018 | $1,451,000 | -28.6% | 56,700 | -8.8% | 0.00% | -33.3% |
| Q3 2018 | $2,032,000 | +33.2% | 62,200 | -7.6% | 0.00% | +50.0% |
| Q2 2018 | $1,526,000 | -14.3% | 67,300 | -8.3% | 0.00% | -33.3% |
| Q1 2018 | $1,780,000 | -17.1% | 73,400 | -4.7% | 0.00% | 0.0% |
| Q4 2017 | $2,148,000 | -16.6% | 77,000 | +2.4% | 0.00% | -25.0% |
| Q3 2017 | $2,575,000 | -24.5% | 75,200 | -12.1% | 0.00% | -20.0% |
| Q2 2017 | $3,410,000 | +11.3% | 85,600 | +2.9% | 0.01% | 0.0% |
| Q1 2017 | $3,063,000 | +9.4% | 83,200 | -5.2% | 0.01% | 0.0% |
| Q4 2016 | $2,799,000 | -17.6% | 87,800 | -6.3% | 0.01% | -16.7% |
| Q3 2016 | $3,396,000 | +76.3% | 93,700 | +10.4% | 0.01% | +100.0% |
| Q2 2016 | $1,926,000 | +16.9% | 84,900 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $1,647,000 | +8.1% | 87,600 | -5.7% | 0.00% | +50.0% |
| Q4 2015 | $1,523,000 | +49.2% | 92,900 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,021,000 | -18.4% | 92,900 | -3.3% | 0.00% | 0.0% |
| Q2 2015 | $1,251,000 | -27.5% | 96,069 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,726,000 | 0.0% | 96,069 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,726,000 | +114.1% | 96,069 | +174.7% | 0.00% | +100.0% |
| Q3 2014 | $806,000 | -27.7% | 34,969 | -0.0% | 0.00% | -50.0% |
| Q2 2014 | $1,115,000 | – | 34,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |